Readily Diagnostics


Readily Diagnostics (founded 2022 as a university spin-out) develops rapid, instrument-free molecular diagnostics for infectious disease. Their platform combines ligation-dependent padlock probes with isothermal rolling circle amplification and microfluidic integration to provide multiplex pathogen detection with visual or fluorescence readouts. Current offerings include research-use microtiter plate assays and instrument-free microfluidic chips intended for near-patient and laboratory use.

Industries

health-care
health-diagnostics
medical

Nr. of Employees

small (1-50)

Readily Diagnostics

Uppsala, Uppsala Lan, Sweden, Europe


Products

Readily Clinic (microfluidic chip format) - Research Use Only

Credit-card-sized microfluidic molecular test configured for instrument-free, near-patient detection of multiple pathogens from the same sample; visual or optional fluorescence readout.

Readily Research (microtiter plate format) - Research Use Only

Standard microtiter plate molecular assay configured for laboratory throughput; supports fluorescence readout and multiplex detection of viruses and variants.


Services

Start kit evaluation and technical support

Supply of start kits for evaluation (microfluidic chips or plates) with one day of support to integrate assays into research workflows.

Expertise Areas

  • Molecular diagnostics
  • Point-of-care / near-patient testing
  • Microfluidics
  • Assay development and multiplexing
  • Show More (4)

Key Technologies

  • Padlock probe-based target recognition
  • Rolling circle amplification (RCA)
  • Isothermal amplification
  • Microfluidic chip-based assays
  • Show More (4)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.